Since docetaxel is a microtubule inhibitor which is most effective in mitotic phase, we found that sensitivity of colorectal cancer cells to docetaxel was indeed increased in RKO and HCT116 when RASSF10 expression was restored. The gene discussed is RASSF10; the disease is colorectal cancer.